Lv4
581 积分 2021-12-07 加入
Phase I Trial of a Novel Anti-HER2 Antibody–Drug Conjugate, ARX788, for the Treatment of HER2-Positive Metastatic Breast Cancer
29天前
已完结
Redefining first-line standards: The role of next-generation HER2-Targeted therapies in HER2-positive metastatic breast cancer
29天前
已完结
Right-sizing treatment for HER2-positive breast cancer: evolving algorithms across the disease continuum
29天前
已完结
Trastuzumab Botidotin Versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A Phase III, Open-Label, Randomized Controlled Trial
30天前
已完结
Neoadjuvant Trastuzumab and Pyrotinib for Locally Advanced HER2-Positive Breast Cancer (NeoATP): Primary Analysis of a Phase II Study
1个月前
已完结
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study
1个月前
已完结
HER2-Positive Metastatic Colorectal Cancer
1个月前
已完结
Peridialytic Erythropoietin versus Roxadustat in Hemodialysis-Dependent Chronic Kidney Disease Patients
1个月前
已完结
Advancing neoadjuvant therapy with inetetamab for HER2-Positive breast cancer
1个月前
已完结
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
1个月前
已完结